Naoyuki Sato

Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factors

Ryuichi Morishita, R. Morishita, N. Sato, 2013, Front. Aging Neurosci..

Associations of complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) genotypes with subtypes of polypoidal choroidal vasculopathy.

Yoshihiro Mizutani, Akiyuki Kawamura, Tomohiro Nakayama, 2011, Investigative ophthalmology & visual science.

Validation of Aβ1–40 administration into mouse cerebroventricles as an animal model for Alzheimer disease

Masanobu Kano, Ryuichi Morishita, R. Morishita, 2009, Brain Research.

Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes

Ryuichi Morishita, R. Morishita, N. Sato, 2010, Proceedings of the National Academy of Sciences.

Gene transfer into adult rat spinal cord using naked plasmid DNA and ultrasound microbubbles

Ryuichi Morishita, Toshio Ogihara, Yasufumi Kaneda, 2005, The journal of gene medicine.

α1‐Antichymotrypsin as a risk modifier for late‐onset Alzheimer's disease in Japanese apolipoprotein E ε4 allele carriers

Toshio Ogihara, Toshiaki Sakai, T. Ogihara, 1997 .